{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:04:47Z","timestamp":1790859887842,"version":"4.1.0"},"reference-count":44,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Res &amp; Perspec"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Phosphoinositide 3\u2010kinases, delta (PI3K\u03b4) and gamma (PI3K\u03b3) are enriched in immune cells and regulate the development and function of innate and adaptive immunity. Dual PI3K\u03b4\u03b3 inhibitors are considered high value targets for their potential to treat a variety of immune\u2010mediated diseases, but their discovery has been challenging. Here we describe the preclinical pharmacology of HM5023507, an orally active dual inhibitor of \u03b4\u03b3 isoforms in immune signaling. HM5023507 inhibited PI3K\u03b4 and PI3K\u03b3 isoforms with greater than 100\u2010fold selectivity against PI3K\u03b1 and PI3K\u03b2 in recombinant enzymatic assays and in primary human immune cells with an exquisite selectivity against other targets. HM5023507 attenuated the PI3K\u03b4\/\u03b3 signaling in human basophils (IC<jats:sub>50<\/jats:sub>: 42\/340\u00a0nmol\/L; selectivity ratio\u00a0~1:8). HM5023507 attenuated the activation and function of human B and T cells, Th17 differentiation of CD4 T cells in the blood of healthy donors and rheumatoid arthritis patients, and cytokine and IgG production in human T and B cell cocultures, in vitro. Orally dosed HM5023507 attenuated PI3K \u03b4\/\u03b3\u2010mediated immune signaling in the rat in a dose\u2010related manner. In addition, HM5023507 inhibited semiestablished collagen\u2010induced arthritic inflammation in the rats (ED<jats:sub>50<\/jats:sub> of 0.25mg\/kg, p.o. BID or 0.5\u00a0mg\/kg, QD, AUC: 1422\u00a0ng\/mL*h), improved histopathology\u2010 and micro\u2010computed tomography (\u00b5CT)\u2010based indices of joint damage, bone destruction, and attenuated the levels of anti\u2010collagen antibody, with an overall anti\u2010inflammatory profile matching that of a TNF\u03b1 neutralizing antibody. The PI3K \u03b4\u03b3 inhibitory profile of HM5023507 and its selectivity make it a useful tool to further delineate immunobiology of dual PI3K \u03b4\u03b3 targeting.<\/jats:p>","DOI":"10.1002\/prp2.559","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T23:07:31Z","timestamp":1578956851000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunological characterization of HM5023507, an orally active PI3K\u03b4\/\u03b3 inhibitor"],"prefix":"10.1002","volume":"8","author":[{"given":"Yu","family":"Cai","sequence":"first","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ren","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"He","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xiao","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jia","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sai","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxiu","family":"Dai","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Li","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Su","sequence":"additional","affiliation":[{"name":"Hutchison MediPharma, Research and Development Center Pudong Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ngo","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical R&amp;D, LLC. San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Castro","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical R&amp;D, LLC. San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Acton","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical R&amp;D, LLC. Spring House PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai\u2010Ping","family":"Fung\u2010Leung","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical R&amp;D, LLC. San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical R&amp;D, LLC. Spring House PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Venable","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical R&amp;D, LLC. San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5332-7304","authenticated-orcid":false,"given":"Tadimeti S.","family":"Rao","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutical R&amp;D, LLC. San Diego CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874312901206010245"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm300847w"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0249"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.28"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-275305"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.04.001"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2036"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/82_2010_79"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01298"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.237347"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.6b00238"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2010.01.010"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2013.09.017"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-850461"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813904"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019833992"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2426"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.08.005"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-0944"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900432"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-086751"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.8.5122"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095946"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20112092"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2882"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-015-1352-5"},{"key":"e_1_2_9_28_1","unstructured":"LeffR KumarS NikulenkovaN KaidashevI AllenK DunbarJ SternH AdamsJ WeinblattM.Safety and efficacy results of a phase 2 double\u2010blind placebo\u2010controlled clinical study of duvelisib with background methotrexate (MTX) in adults with moderate\u2010to\u2010severe rheumatoid arthritis (RA).2015. ACR\/ARHP Annual Meeting. Abstract 2138."},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b02014"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.123026"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020805"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058966"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343812"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-232330"},{"key":"e_1_2_9_35_1","article-title":"Does the PI3K pathway promote or antagonize regulatory T cell development and function?","volume":"3","author":"Soond DR","year":"2012","journal-title":"Front Imm"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.5.2783"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13805"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.4.2236"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000259"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.11.7891"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0778-4"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12790"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.01.030"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1284"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838266"}],"container-title":["Pharmacology Research &amp; Perspectives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.559","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/prp2.559","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T09:08:18Z","timestamp":1694164098000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/prp2.559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1002\/prp2.559"],"URL":"https:\/\/doi.org\/10.1002\/prp2.559","archive":["Portico"],"relation":{},"ISSN":["2052-1707","2052-1707"],"issn-type":[{"value":"2052-1707","type":"print"},{"value":"2052-1707","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]},"assertion":[{"value":"2019-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00559"}}